Skip to main content

Axos ONE

Axos ONE
Your money deserves up to 4.51% APY.* Reach your financial goals faster. Axos ONE helps you get there with high-APY savings that's up to 11x the national average.

Featured

Next.js Partial Prerendering: The End of the Static vs. Dynamic Trade-off

In modern web architecture, developers have historically faced a binary choice that dictates the performance profile of their applications: Static Generation or Server-Side Rendering (SSR) . Static generation offers excellent edge performance but lacks personalization. SSR provides full dynamism but suffers from slower Time to First Byte (TTFB) due to server computation. This trade-off forces a compromise: access a single cookie, and the entire page often opts out of static optimization. Next.js recently introduced Partial Prerendering (PPR) to dismantle this dichotomy. PPR allows a page to be composed of a static outer shell (served instantly from the edge) while distinct components stream in dynamic data in parallel. While the concept is powerful, the implementation details have undergone a significant architectural pivot—moving from error-based detection to a more robust, promise-driven mechanism. The Core Objective: Web Vitals The engineering goal of PPR is to optimize Core Web V...

Exclusive DEALS

Cybersecurity News: Google Cloud Security Chief Sees Bright Future for Cybersecurity

Cybersecurity News: Google Cloud Security Chief Sees Bright Future for Cybersecurity

Cybersecurity News Google Cloud Security Chief Sees Bright Future for Cybersecurity

Google Cloud, a global leader in tech infrastructure and services, is experiencing rapid growth, with a 35% year-over-year revenue jump and a $1.9 billion operating income. This success highlights the critical importance of strong cybersecurity to safeguard its vast platform. The Chief Information Security Officer's (CISO) positive outlook signals strong confidence in future security innovations and advancements.

For the latest news in cybersecurity and technology, stay informed with us!

Comments